Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Rosa A. van Amerongen, Valesca P. Retel, Veerle M. H. Coupe, Petra M. Nederlof, Maartje J. Vogel, Wim H. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalEcancermedicalscience
Volume10
DOIs
Publication statusPublished - 28 Oct 2016

Cite this

van Amerongen, Rosa A. ; Retel, Valesca P. ; Coupe, Veerle M. H. ; Nederlof, Petra M. ; Vogel, Maartje J. ; van Harten, Wim H. / Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis. In: Ecancermedicalscience. 2016 ; Vol. 10.
@article{72d925c9130448d2b2309ecb5930caaf,
title = "Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis",
keywords = "Next-generation sequencing, test costs, budget impact, melanoma, NSCLC, personalised medicine, targeted therapy",
author = "{van Amerongen}, {Rosa A.} and Retel, {Valesca P.} and Coupe, {Veerle M. H.} and Nederlof, {Petra M.} and Vogel, {Maartje J.} and {van Harten}, {Wim H.}",
year = "2016",
month = "10",
day = "28",
doi = "10.3332/ecancer.2016.684",
language = "English",
volume = "10",
journal = "Ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",

}

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis. / van Amerongen, Rosa A.; Retel, Valesca P.; Coupe, Veerle M. H.; Nederlof, Petra M.; Vogel, Maartje J.; van Harten, Wim H.

In: Ecancermedicalscience, Vol. 10, 28.10.2016.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

AU - van Amerongen, Rosa A.

AU - Retel, Valesca P.

AU - Coupe, Veerle M. H.

AU - Nederlof, Petra M.

AU - Vogel, Maartje J.

AU - van Harten, Wim H.

PY - 2016/10/28

Y1 - 2016/10/28

KW - Next-generation sequencing

KW - test costs

KW - budget impact

KW - melanoma

KW - NSCLC

KW - personalised medicine

KW - targeted therapy

U2 - 10.3332/ecancer.2016.684

DO - 10.3332/ecancer.2016.684

M3 - Article

VL - 10

JO - Ecancermedicalscience

JF - Ecancermedicalscience

SN - 1754-6605

ER -